297 related articles for article (PubMed ID: 20802021)
21. Oral contraceptives in relation to breast cancer.
Malone KE; Daling JR; Weiss NS
Epidemiol Rev; 1993; 15(1):80-97. PubMed ID: 8405215
[TBL] [Abstract][Full Text] [Related]
22. Health outcomes associated with use of hormonal contraception: breast cancer.
Schneyer R; Lerma K
Curr Opin Obstet Gynecol; 2018 Dec; 30(6):414-418. PubMed ID: 30239373
[TBL] [Abstract][Full Text] [Related]
23. Oral contraceptive agents and breast cancer: a population-based case-control study.
Rohan TE; McMichael AJ
Med J Aust; 1988 Nov; 149(10):520-6. PubMed ID: 3185321
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer before age 45 and oral contraceptive use: new findings.
Miller DR; Rosenberg L; Kaufman DW; Stolley P; Warshauer ME; Shapiro S
Am J Epidemiol; 1989 Feb; 129(2):269-80. PubMed ID: 2912040
[TBL] [Abstract][Full Text] [Related]
25. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
[TBL] [Abstract][Full Text] [Related]
26. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
[TBL] [Abstract][Full Text] [Related]
27. Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish Women's Lifestyle and Health Cohort Study.
Kumle M; Weiderpass E; Braaten T; Persson I; Adami HO; Lund E
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1375-81. PubMed ID: 12433714
[TBL] [Abstract][Full Text] [Related]
28. Oral contraceptives and breast cancer.
Schlesselman JJ
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1379-87. PubMed ID: 2220962
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer and oral contraceptive use.
Rosenberg L; Miller DR; Kaufman DW; Helmrich SP; Stolley PD; Schottenfeld D; Shapiro S
Am J Epidemiol; 1984 Feb; 119(2):167-76. PubMed ID: 6695896
[TBL] [Abstract][Full Text] [Related]
30. Oral contraceptives and risk of breast cancer.
Paul C; Skegg DC; Spears GF
Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
[TBL] [Abstract][Full Text] [Related]
31. Clinical experience with a triphasic oral contraceptive ('Trinordiol') in young women.
Gaspard UJ; Deville JL; Dubois M
Curr Med Res Opin; 1983; 8(6):395-404. PubMed ID: 6406157
[TBL] [Abstract][Full Text] [Related]
32. Hormonal contraceptive use and breast cancer in Thai women.
Poosari A; Promthet S; Kamsa-ard S; Suwanrungruang K; Longkul J; Wiangnon S
J Epidemiol; 2014; 24(3):216-20. PubMed ID: 24614914
[TBL] [Abstract][Full Text] [Related]
33. Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Narod SA; Dubé MP; Klijn J; Lubinski J; Lynch HT; Ghadirian P; Provencher D; Heimdal K; Moller P; Robson M; Offit K; Isaacs C; Weber B; Friedman E; Gershoni-Baruch R; Rennert G; Pasini B; Wagner T; Daly M; Garber JE; Neuhausen SL; Ainsworth P; Olsson H; Evans G; Osborne M; Couch F; Foulkes WD; Warner E; Kim-Sing C; Olopade O; Tung N; Saal HM; Weitzel J; Merajver S; Gauthier-Villars M; Jernstrom H; Sun P; Brunet JS
J Natl Cancer Inst; 2002 Dec; 94(23):1773-9. PubMed ID: 12464649
[TBL] [Abstract][Full Text] [Related]
34. Oral contraceptive formulation and risk of breast cancer.
Marchbanks PA; Curtis KM; Mandel MG; Wilson HG; Jeng G; Folger SG; McDonald JA; Daling JR; Bernstein L; Malone KE; Wingo PA; Simon MS; Norman SA; Strom BL; Ursin G; Weiss LK; Burkman RT; Spirtas R
Contraception; 2012 Apr; 85(4):342-50. PubMed ID: 22067757
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.
Pike MC; Henderson BE; Krailo MD; Duke A; Roy S
Lancet; 1983 Oct; 2(8356):926-30. PubMed ID: 6138501
[TBL] [Abstract][Full Text] [Related]
36. Oral contraceptives as related to cancer and benign lesions of the breast.
Fasal E; Paffenbarger RS
J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
[TBL] [Abstract][Full Text] [Related]
37. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
Notelovitz M; Kitchens CS; Khan FY
Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
[TBL] [Abstract][Full Text] [Related]
38. Comparison of contraceptive acceptability of levonorgestrel and ethinyl oestradiol administered in one three-phasic (Trionetta) and one monophasic (Neovletta) version.
Carlborg L
Contraception; 1983 May; 27(5):439-52. PubMed ID: 6349925
[TBL] [Abstract][Full Text] [Related]
39. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
[TBL] [Abstract][Full Text] [Related]
40. Prescription contraceptives: countering the risks.
Ruggiero RJ
Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
